Thus, remodeling of these pathways also by alternative, or adjuvant venues to knocking out the MyD88 could play a crucial role in the re-programming of macrophages to prevent the formation of atheroma plaques and advancement of atherosclerosis disease. The gene discussed is MYD88; the disease is atherosclerosis.